Supernus Pharmaceuticals (SUPN) Profit Margin (2011 - 2026)
Supernus Pharmaceuticals (SUPN) profit margin from Jun 30, 2011 to Mar 31, 2026. The current Supernus Pharmaceuticals (SUPN) profit margin is -1.10%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Supernus Pharmaceuticals (SUPN)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -5.36% | -148.05% |
| 2024 | 11.16% | +5036.37% |
| 2023 | 0.22% | -97.61% |
| 2022 | 9.10% | -1.25% |
| 2021 | 9.21% | -62.23% |
| 2020 | 24.39% | -15.26% |
| 2019 | 28.79% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 27.14% | -0.19% |
| 2018 | 27.19% | -11.94% |
| 2018 | 30.88% | +5.98% |
| 2018 | 29.14% | +49.61% |
| 2017 | 19.48% | -1.89% |
| 2017 | 19.85% | -13.34% |
| 2017 | 22.91% | +28.05% |
| 2017 | 17.89% | -58.80% |
| 2016 | 43.42% | -60.10% |
| 2016 | 108.84% | +448.22% |
| 2016 | 19.85% | +81.63% |
| 2016 | 10.93% | +12.54% |
| 2015 | 9.71% | N/A |
| 2015 | 9.71% | -2.48% |
| 2015 | 9.96% | +45.64% |
| 2015 | 6.84% | +165.60% |
| 2015 | 2.57% | -121.12% |
| 2014 | -12.19% | -200.49% |
| 2014 | 12.13% | -216.15% |
| 2014 | -10.45% | -196.88% |
| 2014 | 10.78% | -106.30% |
| 2014 | -171.15% | -21.11% |
| 2013 | -216.94% | -72.84% |
| 2013 | -798.87% | -58.23% |
| 2013 | -1912.70% | -80.43% |
| 2013 | -9771.43% | -20.38% |
| 2013 | -12273.33% | +292.49% |
| 2012 | -3127.03% | -79.12% |
| 2012 | -14977.78% | +34.67% |
| 2012 | -11122.22% | +151.69% |
| 2012 | -4419.05% | -165.69% |
| 2011 | 6727.50% | -106.91% |
| 2011 | -97300.00% | +9788.21% |
| 2011 | -984.00% | -97.19% |
| 2010 | -34963.64% | N/A |
Comparison Supernus Pharmaceuticals (SUPN) profit margin with competitors
Supernus Pharmaceuticals (SUPN) profit margin is -1.10%.